Latest Close
$20.08
Stock Hub
JBIO
Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
$11.80 (+142.51%)
Market Cap
$1.22B
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
52W Range
$6.67 to $28.00
Target Mean Price
$48.50
Beta
Not available
Trailing P/E
Not available
Forward P/E
-8.81
Price / Book
3.34
Company Overview
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.